Document is current
Any future updates will be listed below
-
Authors
Vogt, Kristian https://orcid.org/0009-0001-0137-4464
Fink, Christian Bijan https://orcid.org/0009-0003-9949-3537
Schreibing, Teresa Maria https://orcid.org/0000-0003-0593-5123
Krämer, Stefan https://orcid.org/0009-0004-9485-0969
Reinartz, Sebastian https://orcid.org/0000-0003-1769-4953
Rauen, Thomas https://orcid.org/0000-0002-6544-8901
- License Information
-
More Information
Article History
Received: 15 May 2024
Accepted: 8 July 2024
First Online: 13 August 2024
Declarations
:
: T. Rauen: received consultancy honoraria from Vifor Pharma. K. Vogt, T. Schreibing, S. Krämer, C.B. Fink and S. Reinartz: no competing interest.
: Ethical approval was obtained from our local ethic committee at the University Hospital Aachen (EK 164/19), dated 12th April 2019.
